SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced speakers for the Sequire Cannabis & Psychedelic Conference taking place on April 20, 2022. The event will showcase over 30 cannabis and psychedelic companies hosting 25 minute presentations, one-on-one investor meetings, and keynotes highlighting notable names in these spaces. The panels and featured speakers include a discussion on “Exploring the Value and Application of Botanical and Synthetic Formulations in Psychedelic Medicine,” in which Dr. Matt Johnson, Joel Stanley and David Drapkin will discuss clinical research on psychedelic compounds. “Building an Industry Worthy of the Plant,” will feature Steve DeAngelo and Andrew DeAngelo as they share insider knowledge about the current cannabis landscape, latest developments and what to expect in the near future with expanding cannabis legalization. In addition, during his speech, “Debt Capital for Everyone,” James Dworkin, managing director of Seaport Global Securities, will share insight on the state of the cannabis debt, equity, and M&A markets, and how everyone can access them.
To view the full press release, visit https://ibn.fm/IHJo2
About SRAX Inc.
SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
